They are talking about us! Allurion's newsroom

BBC
bloomberg
Daily Mail
Forbes
Tech Crunch
The Boston Globe
The Guardian
The wall street journal
Scientific American
Good Morning Britain
The New-York Times
The first and only procedureless intragastric balloon

The first and only procedureless intragastric balloon for safe and rapid weight-loss

BARIATRIC NEWS - ”Elipse offers a unique and very attractive way of delivering an outpatient weight management solution for those who either don’t qualify for bariatric surgery, or who would prefer not to undergo a more invasive procedure," said Professor David Kerrigan, Bariatric Surgeon, UK

Tablette trickst den Magen aus

Tablette trickst den Magen aus

FRAU IM LEBEN - Durch das zusätzliche Volumen im Bauch werden Sie schneller satt, essen weniger und nehmen ab – bis zu 15 Kilogramm in vier Monaten. Zur Behandlung gehört eine sechsmonatige Ernährungsberatung mit Hilfsmitteln wie einer digitalen Körperfett-Waage und einer App. Der Ballon selbst wird nach vier Monaten automatisch über den Stuhlgang ausgeschieden – völlig schmerzfrei.

Obesity-focused Allurion scoops up $34M in new funding

Obesity-focused Allurion scoops up $34M in new funding

BIOWORLD - [Company CEO Shantanu Gaur] highlighted that the company’s success with the financing points to the modern consumer, who is researching his or her options on new interventions and experiences. “And more companies, I think, over the next five to 10 years will start treating them not just as patients inside a very complex health care system, but actual consumers who are choosing to go forward with one product or experience over another.” To that end, the consumer is at the center of what his company does.

Allurion raises funds for swallowable weight loss balloon

Allurion raises funds for swallowable weight loss balloon

MEDICAL DEVICE NETWORK - Allurion co-founder and CEO Shantanu Gaur said: “[...] We believe that our focus on a 360-degree consumer experience that delivers life-changing results has differentiated us from the competition and driven unprecedented demand. As a result, Allurion is now the leader in a new category with massive potential.”

How can we help?

We’re here to answer any questions you may have. 


In case of a medical emergency or other medical questions, please contact your Elipse clinic or local healthcare provider.

You are

This content is not intended for a U.S audience. It describes our product, which has not been approved by the U.S. Food and Drug Administration. For the US website please click here

I understand